
Please try another search
Imugene Limited is an Australia-based clinical-stage immuno-oncology company. The Company is engaged in developing a range of new immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies, such as CAR T’s for solid tumors. Its PD-1 B-cell immunotherapy (PD1-Vaxx), aims to induce the body to produce polyclonal antibodies that block PD-1 signaling, and thus produce an anticancer effect. Its HER-Vaxx is a B-cell activating cancer immunotherapy designed to treat tumors that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. Its clinical trial candidates include VAXINIA (CF33 + hNIS), CHECKvacc (CF33 + hNIS + PD-L1), B-Vaxx and others.
Name | Age | Since | Title |
---|---|---|---|
Axel Hoos | 52 | 2013 | Independent Non-Executive Director |
Leslie Chong | - | 2015 | CEO, MD & Executive Director |
Paul Edward-Alexander Hopper | 65 | 2012 | Executive Chairman |
Pravin T. P. Kaumaya | - | 2018 | Member of Scientific Advisory Board |
Neil H. Segal | - | 2014 | Member of Scientific Advisory Board |
Yelena Y. Janjigian | - | 2016 | Scientific Advisory Board Member |
Ursula Wiedermann | - | 2015 | Member of Scientific Advisory Board |
Josep Tabernero | - | 2018 | Member of Scientific Advisory Board |
Peter Schmid | - | 2017 | Member of Scientific Advisory Board |
Yuman Fong | - | 2019 | Chair of Oncolytic Virotherapy Scientific Advisory Board |
Charles S. Walker | - | 2015 | Independent Non-Executive Director |
Tanios Bekaii-Saab | - | 2018 | Member of Scientific Advisory Board |
Jens W. Eckstein | - | 2019 | Independent Non-Executive Director |
Lesley Russell | 61 | 2019 | Independent Non-Executive Director |
Rebecca Auer | - | - | Member of Scientific Advisory Board |
Prasad S. Adusumilli | - | 2019 | Member of Scientific Advisory Board |
Saul J. Priceman | - | - | Member of Oncolytics Virotherapy Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review